Pharmaceutical Industry Information Portal


All posts by tag


No deaths linked to EpiVacCorona vaccine registered in Russia

EpiVacCorona is a single-dose synthetic peptide vaccine against COVID-19 developed by the Vector State Research Center of Virology and Biotechnology.

Russia sends files to register coronavirus vaccine for animals to 4 countries

Carnivak-Cov was developed by the Federal Center for Animal Health. It is the first in the world and currently the only registered vaccine against the coronavirus for animals.

Pre-clinical trials of intranasal version of Sputnik V completed

The vaccine helps to develop a local immunity, therefore it will be most likely recommended to those who have contraindications to injections.

EC approves contract for a potential COVID-19 vaccine with Novavax

Under this contract, Member States will be able to purchase up to 100 million doses of the Novavax vaccine, with an option for 100 million additional doses.

Sanofi acquires biotech company Translate Bio for $3.2 billion

Sanofi and Translate Bio have a shared commitment to innovation in the mRNA space.

Betuvax coronavirus vaccine clinical trials to begin in September

The Betuvax-CoV-2 is a split recombinant vaccine of the basis of spherical particles with the coronavirus surface antigen (protein).

Expert Articles